MEDICAL ARCHEOLOGY. An old drug candidate, from the 1980s, can help new clinical trials find the right patient category for new cancer drugs. That was the conclusion of a researcher couple at Sahlgrenska Academy that dug through the medical literature and discovered a forgotten drug molecule. Work with a new molecule, called RVX2135, awakened interest in the discarded drug candidate. Researcher couple, Jonas and Lisa Nilsson, had shown that RVX2135…
Swedish Research Collaboration Yields New Strategy for Cancer Treatment
In an article published in the latest issue of Nature, Swedish cancer researchers present a completely new approach to treating cancer: killing cancer cells by using their own reactive oxygen species. Listen to Jonas Nilsson, Sahlgrenska Cancer Center, when he explains how it works.